It's nearly impossible to understand how Traci and Kevin felt when they learned that their son, Nicholas, only 2-years old, was diagnosed with leukemia. Doctors told Traci and Kevin that the best course of treatment for Nicholas was chemotherapy.
Every time a cord blood unit leaves ViaCord for use - it's a meaningful event. It represents the hope and potential of providing treatment for a family's loved one. Recently, ViaCord marked the release of the 150th unit for therapeutic use.
This month, researchers at the Salk Institute for Biological Studies are reporting that umbilical cord blood can be used to make induced pluripotent stem cells (iPS)-that are immunologically immature with properties similar to human embryonic stem cells.
